The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Hematopoietic Recovery using Multi-Cytokine Therapy in 8 Patients Presenting Radiation-Induced Myelosuppression after Radiological Accidents
Abstract
Treatment of accidental radiation-induced myelosuppression is primarily based on supportive care and requires specific treatment based on hematopoietic growth factors injection or hematopoietic cell transplantation for the most severe cases. The cytokines used consisted of pegylated erythropoietin (darbepoetin alfa) 500 IU once per week, pegylated G-CSF (pegfilgrastim) 6 mg × 2 once, stem cell factor 20 µg.kg-1 for five days, and romiplostim (TPO analog) 10 µg.kg -1 once per week, with different combinations depending on the accidents. As the stem cell factor did not have regulatory approval for clinical use in France, the French regulatory authorities (ANSM, formerly, AFSSAPS) approved their compassionate use as an investigational drug "on a case-by-case basis". According to the evolution and clinical characteristics, each patient's treatment was adopted on an individual basis. Daily blood count allows initiating G-CSF and SCF delivery when granulocyte <1,000/mm3, TPO delivery when platelets <50,000/mm3, and EPO when Hb<80 g/L. The length of each treatment was based on blood cell recovery criteria. The concept of "stimulation strategy" is linked to each patient's residual hematopoiesis, which varies among them, depending on the radiation exposure's characteristics and heterogeneity. This paper reports the medical management of 8 overexposed patients to ionizing radiation. The recovery of bone marrow function after myelosuppression was accelerated using growth factors, optimi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other growth factors used with the intention of stimulating recovery of the bone marrow in patients with ARS include interleukin-3 (IL-3), erythropoietin (EPO), megakaryocyte growth and development factor (MGDF), stem cell factor (SCF), and/or thrombopoietin (TPO) (Benderitter et al., 2021).”
From Medical countermeasures for the hematopoietic-subsyndrome of acute radiation syndrome in space (2022) · cites this paper as Benderitter et al., 2021
Citations
Cites
Clonal and systemic analysis of long-term hematopoiesis in the mouse.Preprint
Jordan, C. T., & Lemischka, I. R. (1990) · Genes & Development · doi:10.1101/gad.4.2.220 · Cited by 550
The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950–2001
Hsu, W.-L., Preston, D. L., Soda, M., Sugiyama, H., Funamoto, S., Kodama, K., Kimura, A., Kamada, N., Dohy, H., Tomonaga, M., et al. (2013) · Radiation Research · doi:10.1667/rr2892.1 · Cited by 409
Hematologic consequences of exposure to ionizing radiation
Dainiak, N. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(02)00802-0 · Cited by 362
Bey, É., Prat, M., Duhamel, P., Benderitter, M., Brachet, M., Trompier, F., Battaglini, P., Ernou, I., Boutin, L., Gourven, M., et al. (2010) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2009.00562.x · Cited by 217
Self-citationFarese, A. M., Hunt, P., Grab, L. B., & MacVittie, T. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118652 · Cited by 181
Acute radiation syndrome caused by accidental radiation exposure - therapeutic principles
Dörr, H., & Meineke, V. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-126 · Cited by 174
Molineux, G., Migdalska, A., Szmitkowski, M., Zsebo, K. M., & Dexter, T. M. (1991) · Blood · doi:10.1182/blood.v78.4.961.961 · Cited by 168
Bone Marrow Transplantation after the Chernobyl Nuclear Accident
Baranov, A., Gale, R. P., Guskova, A. K., Piatkin, E. K., Gd, S., Muravyova, L., Champlin, R. E., Nb, D., Yevseeva, L., Ln, P., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907273210401 · Cited by 160
Hérodin, F., Bourin, P., Mayol, J.-F., Lataillade, J., & Drouet, M. (2003) · Blood · doi:10.1182/blood-2002-06-1634 · Cited by 139
Self-citationRecombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates
Andrews, R., Knitter, G., Bartelmez, S., Langley, K. E., Farrar, D., Hendren, R. W., Appelbaum, F. R., Bernstein, I. D., & Zsebo, K. M. (1991) · Blood · doi:10.1182/blood.v78.8.1975.1975 · Cited by 136
Research works printed but not linked: 3
- AM El-Naggar, MH Mohammad, MA Gomaa, "The Medical Basis for Nuclear Accident Preparedness. The Clinical Care of Victims. Proceedings of the Fourth International REAC/TS Conference on the Medical Basis for Radiation-Accident Preparedness (held March 6-8, 2001, in Orlando, Florida)." "The radiological accident at Meet Halfa, Qaluobiya, Egypt." 316 (2002)
- V. Jinaratana, "The medical basis for radiation-accidents preparedness. The Clinical care of victims proceeding of the fourth international REAC/TS conference on the medical basis for radiation accidents preparedness (held March 6-8, 2001, in Orlando, Florida)." "The radiological accident in Thailand." 283 (2002)
- T MacVittie and A Faresse "The medical basis for radiation-accidents preparedness the clinical care of victims proceeding of the fourth international REAC/TS conference on the medical basis for radiation accidents preparedness (held March 6-8, 2001, in Orlando, Florida)." "Cytokine-based treatment for acute radiation-induced myelosuppression: preclinical and clinical perspective." 53 (2002)
Cited by
Zhang, T., Zhou, M., Xiao, D., Liu, Z., Jiang, Y., Feng, M., Lin, Y., & Cai, X. (2022) · Advanced Science · doi:10.1002/advs.202202058 · Cited by 87
Management of acute radiation syndrome
Arnautou, P., Garnier, G., Maillot, J., Konopacki, J., Brachet, M., Bonnin, A., Amabile, J.-C., & Malfuson, J.-V. (2024) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2024.07.002 · Cited by 24
Self-citationPhipps, A. J., Bergmann, J. N., Albrecht, M. T., Singh, V. K., & Homer, M. J. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00546-22 · Cited by 20
Development of radiation countermeasure agents for acute radiation syndromes
Guan, B., Li, D., & Meng, A. (2023) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12339 · Cited by 19
An Overview of Radiation Countermeasure Development in Radiation Research from 1954 to 2024
Kiang, J. G., Cannon, G., & Singh, V. K. (2024) · Radiation Research · doi:10.1667/rade-24-00036.1 · Cited by 17
Metadata
- Authors
- Benderitter, M., Herrera-Reyes, E., Gigov, Y., Souleau, B., Huet, C., Trompier, F., Fagot, T., Grégoire, E., Malfuson, J. V., Konopacki-Potet, J., Buglova, E., Lataillade, J.-J., Tamarat, R., Gourmelon, P., & de Revel, T.
- Affiliations
- Institut de Radioprotection et de Sûreté Nucléaire (FR)
- Military Hospital, Department of Hematology and Chemotherapy for Solid Tumors, Sofia, Bulgaria
- Hôpital d'instruction des Armées Percy (FR)
- International Atomic Energy Agency (AT)
- Ecole du Val de Grâce, 75005 Paris, France
- Corresponding author
- Benderitter, Marc
- Venue
- Radiation Research
- Publisher
- Radiation Research Society
- Published
- 2021-09-23
- Volume
- 196
- Issue
- 6
- Pages
- 668-679
- ISSN
- 0033-7587 (ISSN-L)
- 1938-5404
- OpenAlex
- W3201501110
- Cited by
- 15
- References
- 57
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 2 · 2022: 4
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiation Research (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- radiation-induced myelosuppression, hematopoietic recovery, pegfilgrastim, darbepoetin alfa, romiplostim, stem cell factor, radiation accidents, hematopoietic growth factors, compassionate use, bone marrow function
- MeSH terms
- Bone Marrow, Humans, Whole-Body Irradiation, Cytokines, Radioactive Hazard Release
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hematopoietic Recovery using Multi-Cytokine Therapy in 8 Patients Presenting Radiation-Induced Myelosuppression after Radiological Accidents. https://app.cochat.ai/papers/10.1667/rade-21-00169.1
- The paper
- Benderitter, M., Herrera-Reyes, E., Gigov, Y., Souleau, B., Huet, C., Trompier, F., Fagot, T., Grégoire, E., Malfuson, J. V., Konopacki-Potet, J., Buglova, E., Lataillade, J.-J., Tamarat, R., Gourmelon, P., & de Revel, T. (2021). Hematopoietic Recovery using Multi-Cytokine Therapy in 8 Patients Presenting Radiation-Induced Myelosuppression after Radiological Accidents. Radiation Research. https://doi.org/10.1667/rade-21-00169.1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.